Skip to main content
. 2016 Jan 5;6(1):e708. doi: 10.1038/tp.2015.190

Table 2. Maternal antidepressant exposure before and during pregnancy associated with risk for (a) ASD and (b) ADHD.

(a)
Antidepressant exposure ASD Controls ASD versus ASD-matched controlsa
  1245 (%) 3405 (%) Unadjusted Model 1 Model 2
      OR (95% CI) OR (95% CI) OR (95% CI)
Time period
 Prepregnancy 4.6 3.6 1.29 (0.93−1.77) 1.63 (1.02−2.54)* 1.54 (1.02−2.30)*
 Pregnancy (preconception delivery) 2.2 2.3 0.99 (0.63−1.51) 1.13 (0.61−2.00) 0.90 (0.50−1.54)
 Preconception (conception−30 days) 1.0 0.9 1.14 (0.57−2.14) 1.62 (0.62−3.79) 1.12 (0.46−2.47)
 First trimester 1.4 1.3 1.07 (0.59−1.86) 1.10 (0.45−2.41) 0.89 (0.40−1.78)
 Second trimester 1.3 1.1 1.18 (0.63−2.08) 1.39 (0.59−2.99) 1.11 (0.50−2.26)
 Third trimester 1.4 1.4 1.00 (0.56−1.72) 1.20 (0.53−2.47) 0.85 (0.38−1.74)
(b)
Antidepressant exposure ADHD Controls ADHD versus ADHD-matched controlsa
  1701 (%) 3797 (%) Unadjusted Model 1 Model 2
      OR (95% CI) OR (95% CI) OR (95% CI)
Time period
 Prepregnancy 3.1 3.8 1.22 (0.89−1.66) 1.48 (1.01−2.15)* 1.50 (1.00−2.20)*
 Pregnancy (preconception delivery) 1.7 1.5 0.91 (0.56−1.42) 1.00 (0.56−1.71) 0.97 (0.53−1.69)
 Preconception (conception−30 days) 0.8 0.7 0.92 (0.45−1.77) 1.04 (0.43−2.29) 1.01 (0.41−2.26)
 First trimester 1.1 0.7 0.67 (0.33−1.24) 0.72 (0.31−1.52) 0.69 (0.29−1.49)
 Second trimester 0.9 0.8 0.89 (0.46−1.63) 1.13 (0.51−2.28) 1.11 (0.50−2.26)
 Third trimester 1.0 0.6 0.64 (0.31−1.22) 0.75 (0.30−1.65) 0.73 (0.29−1.62)

Abbreviations: ASD, autism spectrum disorder; ADHD, attention-deficit hyperactivity disorder; CI, confidence interval; OR, odds ratio. aUnadjusted and adjusted risk of ADHD and ASD compared with ADHD- and ASD-matched controls respectively; Significance at P<0.05. Model 1 is adjusted for gender, race, birth year, insurance type, and median income tertile. Model 2 is adjusted for variables in Model 1 and past history of maternal depression.